在瘤学中潜在的治疗标:蛋白棕化 (综述)
Shiping Hao1, Yongming Mei1, Shaolin Chen2
1The Public Experimental Center of Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China.
Oncology reports
|July 19, 2025
概括
像棕化这样的翻译后修改 (PTM) 对蛋白质功能和瘤生物学至关重要. 了解异常棕细胞化为向癌症治疗提供了新的途径.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 翻译后修改 (PTMs) 会使蛋白质组多样化,并影响癌症的特征,如扩散和转移.
- 棕化是一种可逆的基于脂质的PTM,影响蛋白质的稳定性,局部化,相互作用和信号传递.
- 失调的棕细胞结合与瘤发生有关,使其成为潜在的治疗点.
研究的目的:
- 为了审查蛋白质棕代谢的生物化学机制.
- 综合当前关于棕代谢在瘤进展,免疫调节和新陈代谢中的作用的知识.
- 为开发向癌症治疗提供洞察力.
主要方法:
- 关于生物化学机制的文献综述.
- 综合了当前关于棕结合在癌症中的功能的研究.
- 分析棕化在瘤生物学,免疫力和新陈代谢中的作用.
主要成果:
- 棕化关键调节蛋白质的稳定性,膜协会和信号传导.
- 异常的棕化与瘤进展的各个方面有关.
- 棕化会影响免疫反应和与癌症相关的代谢途径.
结论:
- 了解棕化机制和作用是推进癌症治疗的关键.
- 向异常的棕化通路为新瘤治疗提供了一个有前途的战略.
- 本综述为未来的治疗开发提供了全面的概述.
相关概念视频
Covalently Linked Protein Regulators
7.2K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.2K
Protein Kinases and Phosphatases
13.4K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Phosphorylation
51.2K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
51.2K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


